Sign In
23 Jan 2009 07:00
|
Press Release |
23 January 2009 |
Cyprotex PLC
("Cyprotex" or "the Company")
Cyprotex PLC (AIM: CRX), the drug discovery technology and information company, announces a trading update on its performance in the calendar year ending 31 December 2008.
Trading in the months of November and December 2008 was stronger than anticipated and as a result the Directors expect 2008 full year net profits (including significant adjustments for non-recurring costs) to be in excess of the current market expectations
- Ends -
For further information:
|
Cyprotex PLC |
|
|
Dr. Anthony Baxter, Chief Executive Officer |
Tel: +44 (0) 1625 505 100 |
|
ir@cyprotex.com |
www.cyprotex.com |
|
Nomura Code Securities Limited |
|
|
Charles Walker, Corporate Finance |
Tel: +44 (0) 20 7776 1200 |
|
cew@nomuracode.com |
www.codesecurities.com |
Media enquiries:
|
Pelham PR |
|
|
Simon Miller |
Tel: +44 (0) 20 3178 4419 |
|
simon.miller@pelhampr.com |
www.pelhampr.com |
CRX.L (CRX)
Follow the stocks
